companydata.dkcompanydata.dk

ZEALAND PHARMA A/S: Financial statements 2024

CVR: 20045078

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 62,691,000 and a net result of DKK -1,078,828,000 compared with DKK -703,739,000 the year before. That is a decrease of 81.7% compared with the year before. The profit margin was -1,720.9%. Equity in the 2024 report amounted to DKK 8,616,742,000. The solvency ratio was 90.6%. The company had 235 employees in the financial year.

Revenue
DKK 62,691,000
Gross Profit
DKK 54,817,000
Profit/Loss
DKK -1,078,828,000
Equity
DKK 8,616,742,000
Total Assets
DKK 9,505,600,000
Employees
235

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202462.7M54.8M-1.1B8.6B235
2023342.8M323.6M-703.7M1.6B235
2022104M EUR104M EUR-1.2B EUR815.9M EUR247
2021292.6M173.8M-1B927.8M346
2020353.3M262.7M-846.7M1.2B297

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

ZEALAND PHARMA A/S publishes interim reportNov 11, 2024

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2024 to September 30, 2024.

ZEALAND PHARMA A/S publishes interim reportAug 21, 2024

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2024 to June 30, 2024.

ZEALAND PHARMA A/S publishes interim reportMay 23, 2024

ZEALAND PHARMA A/S has published its interim report for the period January 1, 2024 to March 31, 2024.

ZEALAND PHARMA A/S: The 2023 annual report is outMar 21, 2024

ZEALAND PHARMA A/S has published its annual report for 2023. Revenue came to DKK 342,788,000, and the net result was DKK -703,739,000.

ZEALAND PHARMA A/S appoints new auditorMar 20, 2024

As of March 20, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZEALAND PHARMA A/S.

ZEALAND PHARMA A/S appoints new auditorMar 20, 2024

As of March 20, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZEALAND PHARMA A/S.

Auditor steps down at ZEALAND PHARMA A/SMar 20, 2024

As of March 20, 2024, EY Godkendt Revisionspartnerselskab has stepped down as auditor of ZEALAND PHARMA A/S.

Ludovic Tranholm Otterbein joins the board of ZEALAND PHARMA A/SMar 20, 2024

As of March 20, 2024, Ludovic Tranholm Otterbein has joined the board of directors of ZEALAND PHARMA A/S.

Nikolaj Frederik Beck joins the board of ZEALAND PHARMA A/SMar 20, 2024

As of March 20, 2024, Nikolaj Frederik Beck has joined the board of directors of ZEALAND PHARMA A/S.

Adam Krisko Nygaard joins the board of ZEALAND PHARMA A/SMar 20, 2024

As of March 20, 2024, Adam Krisko Nygaard has joined the board of directors of ZEALAND PHARMA A/S.

About ZEALAND PHARMA A/S

ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.

Source: annual report 2025, Danish Business Authority